Evidence map›Paper›PMID 28705601›Full record

ReviewPreventive medicine2017

Cannabis use, attitudes, and legal status in the U.S.: A review.

Hannah Carliner, Qiana L Brown, Aaron L Sarvet, Deborah S Hasin

Abstract readReview
In one paragraph

Review in Preventive medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 292 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
292citing papers in PubMed, 7 pooled it
30.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

292 citing papers in PubMed, 7 syntheses or guidelines pooled it, 525 citations in OpenAlex.

  1. The genetics of cannabis lifetime use.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Does the total consumption model apply to cannabis use?Addiction (Abingdon, England) · 2026
    Article
  19. Article
  20. Review

232 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Hannah CarlinerColumbia University, Department of Psychiatry, United States; Columbia University Mailman School of Public Health, Department of Epidemiology, United States; New York State Psychiatric Institute, United States.
Qiana L BrownColumbia University Mailman School of Public Health, Department of Epidemiology, United States; Nathan Kline Institute for Psychiatric Research, New York State Office of Mental Health, United States; New York University School of Medicine, Department of Psychiatry, United States.
Aaron L SarvetNew York State Psychiatric Institute, United States.
Deborah S HasinColumbia University, Department of Psychiatry, United States; Columbia University Mailman School of Public Health, Department of Epidemiology, United States; New York State Psychiatric Institute, United States. Electronic address: dsh2@cumc.columbia.edu.
New York State Psychiatric InstituteNathan Kline Institute for Psychiatric Research · USNew York Psychoanalytic Society and Institute · US

Funding

Substance Abuse Epidemiology Training Program (SAETP) at Columbia UniversityT32DA031099 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DEBORAH S HASIN, Silvia Saboia Martins · 2012 to 2026
$6.1M
State medical marijuana laws and MTF teen marijuana use and attitudes since 1991R01DA034244 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HASIN, DEBORAH S · 2012 to 2016
$3.0M
NIDA NIH HHS R01 DA034244NIDA NIH HHS T32 DA031099
6 · The paper itself

Abstract

Cannabis is widely used among adolescents and adults. In the U.S., marijuana laws have been changing, and Americans increasingly favor legalizing cannabis for medical and recreational uses. While some can use cannabis without harm, others experience adverse consequences. The objective of this review is to summarize information on the legal status of cannabis, perceptions regarding cannabis, prevalence and time trends in use and related adverse consequences, and evidence on the relationship of state medical (MML) and recreational (RML) marijuana laws to use and attitudes. Twenty-nine states now have MMLs, and eight of these have RMLs. Since the early 2000s, adult and adolescent perception of cannabis use as risky has decreased. Over the same time, the prevalence of adolescent cannabis use has changed little. However, adult cannabis use, disorders, and related consequences have increased. Multiple nationally representative studies indicate that MMLs have had little effect on cannabis use among adolescents. However, while MML effects have been less studied in adults, available evidence suggests that MMLs increase use and cannabis use disorders in adults. While data are not yet available to evaluate the effect of RMLs, they are likely to lower price, increase availability, and thereby increase cannabis use. More permissive marijuana laws may accomplish social justice aims (e.g., reduce racial disparities in law enforcement) and generate tax revenues. However, such laws may increase cannabis-related adverse health and psychosocial consequences by increasing the population of users. Dissemination of balanced information about the potential health harms of cannabis use is needed.

Indexed as

AttitudeCannabisHumansMarijuana AbuseMarijuana SmokingMedical MarijuanaPrevalenceRecreationRiskSubstance-Related DisordersSurveys and QuestionnairesUnited StatesMedical MarijuanaCannabisEpidemiologyMarijuanaMedical marijuanaNational surveys

Identifiers

PMID28705601
PMCPMC6348863
OpenAlexW2736295906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.